See more : BankInvest BIX Glob Akt ESG Uni (BAIBGAEUKL.CO) Income Statement Analysis – Financial Results
Complete financial analysis of Cutera, Inc. (CUTR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Cutera, Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
- The Victory Bancorp, Inc. (VTYB) Income Statement Analysis – Financial Results
- CSP Inc. (CSPI) Income Statement Analysis – Financial Results
- Minesto AB (publ) (MINEST.ST) Income Statement Analysis – Financial Results
- Cofina, SGPS, S.A. (CFN.LS) Income Statement Analysis – Financial Results
- Kossan Rubber Industries Bhd (7153.KL) Income Statement Analysis – Financial Results
Cutera, Inc. (CUTR)
About Cutera, Inc.
Cutera, Inc., a medical device company, researches, develops, manufactures, markets, and services laser and energy-based aesthetics systems for practitioners worldwide. The company offers Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truSculpt flex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; excel V+, a vascular and benign pigmented lesion treatment platform; truSculpt iD, for the non-surgical body sculpting market; and Secret RF, a fractional RF microneedling system for tissue coagulation and hemostasis. It also provides enlighten platform, a laser system that is used for tattoo removal, as well as to treat benign pigmented lesions and acne scars; excel HR platform, a hair removal solution for various skin types; and xeo platform, a multi-application platform on which a customer purchases hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity. In addition, the company distributes skincare products; and offers post-warranty services through extended service contracts or direct billing. Further, it provides pulsed light hand pieces for the treatment of discoloration, hair removal, and vascular treatments; and Pearl and Pearl Fractional hand pieces, as well as sells hand piece refills, cycle refills, consumable tips, and marketing brochures through the company's website. The company markets and sells its products through direct sales force to plastic surgeons, dermatologists, gynecologists, family practitioners, primary care physicians, and other qualified practitioners, as well as for physicians performing aesthetic treatments in non-medical offices. Cutera, Inc. was incorporated in 1988 and is headquartered in Brisbane, California.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 212.37M | 252.40M | 231.27M | 147.68M | 181.71M | 162.72M | 151.49M | 118.06M | 94.76M | 78.14M | 74.59M | 77.28M | 60.29M | 53.27M | 53.68M | 83.38M | 101.73M | 100.69M | 75.62M | 52.64M | 39.09M | 28.33M | 19.33M | 9.53M |
| Cost of Revenue | 170.88M | 112.57M | 98.17M | 71.91M | 83.55M | 82.34M | 65.38M | 49.92M | 40.48M | 34.77M | 32.71M | 35.74M | 25.98M | 23.06M | 21.76M | 32.36M | 35.00M | 29.86M | 19.79M | 14.69M | 12.32M | 9.99M | 6.94M | 3.37M |
| Gross Profit | 41.49M | 139.83M | 133.11M | 75.77M | 98.16M | 80.38M | 86.11M | 68.14M | 54.28M | 43.37M | 41.88M | 41.54M | 34.31M | 30.22M | 31.92M | 51.02M | 66.72M | 70.83M | 55.83M | 37.95M | 26.77M | 18.34M | 12.39M | 6.17M |
| Gross Profit Ratio | 19.54% | 55.40% | 57.55% | 51.31% | 54.02% | 49.40% | 56.84% | 57.71% | 57.28% | 55.51% | 56.15% | 53.75% | 56.91% | 56.72% | 59.47% | 61.19% | 65.59% | 70.35% | 73.83% | 72.10% | 68.49% | 64.73% | 64.09% | 64.69% |
| Research & Development | 21.41M | 25.16M | 21.57M | 14.32M | 15.09M | 14.36M | 12.87M | 11.23M | 10.73M | 10.54M | 9.22M | 8.43M | 9.14M | 7.00M | 6.81M | 7.55M | 7.17M | 6.47M | 5.07M | 4.14M | 3.45M | 2.99M | 2.11M | 1.54M |
| General & Administrative | 63.31M | 45.92M | 32.95M | 31.51M | 24.03M | 21.00M | 14.09M | 12.94M | 12.13M | 11.20M | 9.94M | 11.28M | 10.10M | 9.58M | 10.32M | 46.62M | 50.00M | 48.08M | 32.78M | 27.40M | 18.16M | 5.42M | 0.00 | 989.00K |
| Selling & Marketing | 113.00M | 106.95M | 76.76M | 52.77M | 71.11M | 58.42M | 52.07M | 41.56M | 35.94M | 32.25M | 27.98M | 28.66M | 25.50M | 24.74M | 24.29M | 35.35M | 38.28M | 32.89M | 24.80M | 19.05M | 0.00 | 8.60M | 5.43M | 2.79M |
| SG&A | 176.32M | 152.86M | 109.71M | 84.28M | 95.14M | 79.42M | 66.16M | 54.51M | 48.07M | 43.45M | 37.92M | 39.94M | 35.60M | 34.31M | 34.61M | 46.62M | 50.00M | 48.08M | 32.78M | 27.40M | 18.16M | 14.02M | 5.43M | 3.78M |
| Other Expenses | 0.00 | -3.68M | -2.41M | 68.00K | 0.00 | 0.00 | 0.00 | -7.00K | -37.00K | -180.00K | 34.00K | 16.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 18.94M | 1.31M | 1.27M | 0.00 | 0.00 | 2.34M | 0.00 |
| Operating Expenses | 197.72M | 178.02M | 131.28M | 98.60M | 110.23M | 93.77M | 79.03M | 65.74M | 58.80M | 53.99M | 47.14M | 48.37M | 44.74M | 41.32M | 41.42M | 54.17M | 57.17M | 73.49M | 39.16M | 32.80M | 21.61M | 17.01M | 9.88M | 5.32M |
| Cost & Expenses | 368.60M | 290.59M | 229.44M | 170.51M | 193.78M | 176.11M | 144.42M | 115.66M | 99.28M | 88.76M | 79.85M | 84.10M | 70.72M | 64.37M | 63.18M | 86.53M | 92.17M | 103.35M | 58.95M | 47.49M | 33.92M | 27.00M | 16.82M | 8.69M |
| Interest Income | 9.19M | 2.60M | 3.79M | 647.00K | 0.00 | 123.00K | 884.00K | 323.00K | 330.00K | 406.00K | 421.00K | 481.00K | 594.00K | 539.00K | 0.00 | 3.05M | 4.21M | 3.60M | 2.03M | 632.00K | 30.00K | 85.00K | 171.00K | 193.00K |
| Interest Expense | 14.02M | 5.66M | 2.51M | 579.00K | 199.00K | 884.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 8.58M | 8.47M | 5.49M | 6.51M | 4.46M | 3.04M | 1.02M | 982.00K | 1.19M | 1.34M | 1.30M | 1.61M | 637.00K | 717.00K | 860.00K | 904.00K | 913.00K | 869.00K | 689.00K | 1.96M | 443.00K | 382.00K | 0.00 | 0.00 |
| EBITDA | -140.94M | -65.22M | 58.00K | -16.90M | -10.52M | -12.18M | 8.09M | 3.38M | -3.34M | -9.06M | -3.95M | -4.72M | -9.80M | -10.38M | -7.91M | -2.25M | 10.47M | -2.66M | 17.98M | 5.15M | 5.61M | 1.71M | 2.51M | 844.00K |
| EBITDA Ratio | -66.37% | -15.06% | 0.03% | -14.51% | -5.79% | -7.49% | 2.70% | 2.86% | -3.52% | -11.88% | -5.30% | -6.76% | -16.28% | -19.49% | -14.50% | 1.57% | 10.29% | 17.03% | 23.78% | 13.51% | 14.34% | 6.04% | 12.99% | 8.86% |
| Operating Income | -156.23M | -38.19M | -1.29M | -22.83M | -12.06M | -13.39M | 11.08M | 2.40M | -4.52M | -10.62M | -5.26M | -6.83M | -10.43M | -11.10M | -10.34M | -3.15M | 9.56M | -2.66M | 16.67M | 5.15M | 5.16M | 1.33M | 2.51M | 844.00K |
| Operating Income Ratio | -73.57% | -15.13% | -0.56% | -15.46% | -6.64% | -8.23% | 7.31% | 2.03% | -4.77% | -13.59% | -7.05% | -8.83% | -17.30% | -20.83% | -19.27% | -3.78% | 9.39% | -2.64% | 22.05% | 9.79% | 13.21% | 4.70% | 12.99% | 8.86% |
| Total Other Income/Expenses | -5.07M | -42.51M | 1.56M | -579.00K | -199.00K | -123.00K | 884.00K | 323.00K | 293.00K | 226.00K | 455.00K | 497.00K | 614.00K | 583.00K | 1.57M | -508.00K | 4.21M | 3.60M | 2.03M | 632.00K | 30.00K | 85.00K | 171.00K | 193.00K |
| Income Before Tax | -161.30M | -80.70M | 3.39M | -23.41M | -12.26M | -13.52M | 11.96M | 2.72M | -4.23M | -10.39M | -4.80M | -6.33M | -9.82M | -10.52M | -8.77M | -3.66M | 13.76M | 939.00K | 18.71M | 5.79M | 5.19M | 1.42M | 2.68M | 1.04M |
| Income Before Tax Ratio | -75.95% | -31.97% | 1.46% | -15.85% | -6.75% | -8.31% | 7.89% | 2.30% | -4.46% | -13.30% | -6.44% | -8.19% | -16.28% | -19.74% | -16.34% | -4.39% | 13.53% | 0.93% | 24.74% | 10.99% | 13.29% | 5.00% | 13.87% | 10.88% |
| Income Tax Expense | 1.53M | 1.64M | 1.32M | 470.00K | 85.00K | 17.26M | -18.03M | 143.00K | 212.00K | 219.00K | -54.00K | 218.00K | 243.00K | 2.00K | 8.91M | -792.00K | 3.26M | -1.18M | 4.91M | 2.03M | 2.09M | 755.00K | 342.00K | 0.00 |
| Net Income | -162.83M | -82.34M | 2.06M | -23.88M | -12.35M | -30.77M | 29.99M | 2.58M | -4.44M | -10.61M | -4.75M | -6.55M | -10.06M | -10.52M | -17.68M | -2.87M | 10.50M | 2.12M | 13.80M | 3.76M | 3.11M | 660.00K | 2.34M | 1.04M |
| Net Income Ratio | -76.67% | -32.62% | 0.89% | -16.17% | -6.80% | -18.91% | 19.80% | 2.18% | -4.69% | -13.58% | -6.36% | -8.47% | -16.69% | -19.74% | -32.93% | -3.44% | 10.33% | 2.11% | 18.25% | 7.14% | 7.95% | 2.33% | 12.10% | 10.88% |
| EPS | -8.19 | -4.39 | 0.12 | -1.43 | -0.88 | -2.23 | 2.16 | 0.19 | -0.32 | -0.74 | -0.33 | -0.46 | -0.73 | -0.78 | -1.33 | -0.22 | 0.80 | 0.17 | 1.20 | 0.38 | 1.47 | 0.36 | 0.38 | 0.18 |
| EPS Diluted | -8.19 | -4.39 | 0.11 | -1.43 | -0.88 | -2.23 | 2.04 | 0.19 | -0.32 | -0.74 | -0.33 | -0.46 | -0.73 | -0.78 | -1.33 | -0.22 | 0.74 | 0.15 | 1.00 | 0.31 | 0.35 | 0.07 | 0.27 | 0.13 |
| Weighted Avg Shares Out | 19.89M | 18.75M | 17.89M | 16.69M | 14.10M | 13.77M | 13.87M | 13.23M | 13.88M | 14.25M | 14.42M | 14.09M | 13.81M | 13.54M | 13.28M | 12.77M | 13.15M | 12.56M | 11.54M | 8.57M | 2.11M | 1.81M | 1.48M | 1.06M |
| Weighted Avg Shares Out (Dil) | 19.89M | 18.75M | 18.36M | 16.69M | 14.10M | 13.77M | 14.73M | 13.75M | 13.96M | 14.25M | 14.42M | 14.09M | 13.81M | 13.54M | 13.28M | 12.77M | 14.23M | 14.28M | 13.86M | 12.22M | 8.84M | 8.81M | 8.73M | 8.01M |
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Cutera, Inc. with Losses of $100,000 to Contact the Firm
CUTERA SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Cutera To Contact Him Directly To Discuss Their Options
CUTERA, INC. CLASS ACTION ALERT: WOLF HALDENSTEIN ADLER FREEMAN & HERZ LLP REMINDS INVESTORS THAT A SECURITIES CLASS ACTION LAWSUIT HAS BEEN FILED IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF CALIFORNIA AGAINST CUTERA, INC.
ROSEN, LEADING INVESTOR COUNSEL, Encourages Cutera, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CUTR
ROSEN, LEADING INVESTOR COUNSEL, Encourages Cutera, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CUTR
Cutera, Inc. (CUTR) Class Action Alert: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Class Action Against Cutera, Inc.
NEWLY FILED LAWSUIT NOTICE: The Schall Law Firm Encourages Investors in Cutera, Inc. with Losses of $100,000 to Contact the Firm
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Cutera, Inc. (CUTR)
Cutera Investors: 7/24/2023 Filing Deadline in Securities Class Action – Contact Lieff Cabraser
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Cutera, Inc. (CUTR)
Source: https://incomestatements.info
Category: Stock Reports